Literature DB >> 20123669

Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004.

David J Whellan1, Melissa A Greiner, Kevin A Schulman, Lesley H Curtis.   

Abstract

BACKGROUND: Inpatient care is the primary driver of costs for patients with heart failure. It is unclear whether recent advances in heart failure care have reduced the costs to Medicare for the care of inpatients with heart failure. METHODS AND
RESULTS: In a retrospective cohort study of 1 363 977 elderly Medicare beneficiaries hospitalized with heart failure between January 1, 2001, and December 31, 2004, we examined costs to Medicare for all inpatient care, inpatient cardiovascular care, and inpatient heart failure care and the adjusted relationships between patient characteristics and costs. Among 1 363 977 Medicare beneficiaries with an index heart failure hospitalization, 901 885 (66%) had a subsequent inpatient claim during the following year. Noncardiovascular costs accounted for 57% of total inpatient costs, and costs associated with heart failure hospitalizations accounted for 15% of total inpatient costs. No significant changes occurred in total, cardiovascular, and heart failure inpatient costs over time.
CONCLUSIONS: The costs of inpatient care for patients with heart failure are high, but most subsequent inpatient costs are attributable to noncardiovascular and non-heart failure admissions. Further research is needed to identify predictors of costs, so that patients can be stratified according to risk, and to evaluate strategies that target primary cost drivers for patients with heart failure.

Entities:  

Mesh:

Year:  2009        PMID: 20123669      PMCID: PMC2818545          DOI: 10.1161/CIRCOUTCOMES.109.854760

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  28 in total

1.  Prevalence, expenditures, and complications of multiple chronic conditions in the elderly.

Authors:  Jennifer L Wolff; Barbara Starfield; Gerard Anderson
Journal:  Arch Intern Med       Date:  2002-11-11

2.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

3.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Authors:  Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Mark A Brown; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; John E Marley; Trefor O Morgan; Malcolm J West
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

4.  Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community.

Authors:  Khawaja Afzal Ammar; Steven J Jacobsen; Douglas W Mahoney; Jan A Kors; Margaret M Redfield; John C Burnett; Richard J Rodeheffer
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

5.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

Review 6.  Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.

Authors:  Steven Joseph Haas; Theo Vos; Richard E Gilbert; Henry Krum
Journal:  Am Heart J       Date:  2003-11       Impact factor: 4.749

7.  Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Authors:  Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Salim Yusuf; Stuart Pocock
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

8.  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Authors:  K M Fox
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

9.  Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failure.

Authors:  Henry A Glick; Sean M Orzol; Joseph F Tooley; Willem J Remme; Shigetake Sasayama; Bertram Pitt
Journal:  Cardiovasc Drugs Ther       Date:  2002-01       Impact factor: 3.727

10.  High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial.

Authors:  J Sanford Schwartz; Y Richard Wang; John G F Cleland; Longlong Gao; Mark Weiner; Philip A Poole-Wilson
Journal:  Am J Manag Care       Date:  2003-06       Impact factor: 3.247

View more
  23 in total

1.  Hospice care and resource utilization in Medicare beneficiaries with heart failure.

Authors:  Saul Blecker; Gerard F Anderson; Robert Herbert; Nae-Yuh Wang; Frederick L Brancati
Journal:  Med Care       Date:  2011-11       Impact factor: 2.983

2.  Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure.

Authors:  Hakki Kaya; Recep Kurt; Osman Beton; Ali Zorlu; Hasan Yucel; Hakan Gunes; Didem Oguz; Mehmet Birhan Yilmaz
Journal:  Tex Heart Inst J       Date:  2017-02-01

3.  Design of a bioartificial pancreas(+).

Authors:  Emmanuel C Opara; Sayed-Hadi Mirmalek-Sani; Omaditya Khanna; Monica L Moya; Eric M Brey
Journal:  J Investig Med       Date:  2010-10       Impact factor: 2.895

4.  Systematic review of economic burden of heart failure.

Authors:  Asrul Akmal Shafie; Yui Ping Tan; Chin Hui Ng
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

5.  An agent-based simulation model of patient choice of health care providers in accountable care organizations.

Authors:  Abdullah Alibrahim; Shinyi Wu
Journal:  Health Care Manag Sci       Date:  2016-10-04

6.  Comorbid diabetes and end-of-life expenditures among Medicare beneficiaries with heart failure.

Authors:  Saul Blecker; Robert Herbert; Frederick L Brancati
Journal:  J Card Fail       Date:  2011-11-09       Impact factor: 5.712

7.  National Trends in Healthcare-Associated Infections for Five Common Cardiovascular Conditions.

Authors:  P Elliott Miller; Avirup Guha; Rohan Khera; Fouad Chouairi; Tariq Ahmad; Khurram Nasir; Daniel Addison; Nihar R Desai
Journal:  Am J Cardiol       Date:  2019-07-16       Impact factor: 2.778

8.  Estimation of standardized hospital costs from Medicare claims that reflect resource requirements for care: impact for cohort studies linked to Medicare claims.

Authors:  John T Schousboe; Misti L Paudel; Brent C Taylor; Lih-Wen Mau; Beth A Virnig; Kristine E Ensrud; Bryan E Dowd
Journal:  Health Serv Res       Date:  2014-01-24       Impact factor: 3.402

9.  Factors associated with variations in hospital expenditures for acute heart failure in the United States.

Authors:  Boback Ziaeian; Puza P Sharma; Tzy-Chyi Yu; Katherine Waltman Johnson; Gregg C Fonarow
Journal:  Am Heart J       Date:  2014-11-15       Impact factor: 4.749

10.  A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention.

Authors:  David Gregory; Dennis J Scotti; Gregory de Lissovoy; Igor Palacios; Simon Dixon; Brijeshwar Maini; William O'Neill
Journal:  Am Health Drug Benefits       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.